Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Adaptyx Biosciences is a Seattle-based biotechnology company specializing in high-throughput protein engineering to accelerate the discovery and development of next-generation biologics. The company utilizes a proprietary platform that integrates microfluidics, synthetic biology, and machine learning to characterize protein functions at an unprecedented scale. By measuring thousands of protein variants simultaneously, Adaptyx aims to optimize therapeutic properties such as affinity, stability, and specificity. Their technology is designed to overcome traditional bottlenecks in protein design, enabling the creation of more effective medicines and diagnostics. The company's approach focuses on generating high-quality functional data to train predictive models for protein behavior.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Adaptyx Biosciences.